A receptor-antibody hybrid hampering MET-driven metastatic spread

BACKGROUND: The receptor encoded by the MET oncogene and its ligand Hepatocyte Growth Factor (HGF) are at the core of the invasive-metastatic behavior. In a number of instances genetic alterations result in ligand-independent onset of malignancy (MET addiction). More frequently, ligand stimulation o...

Descripción completa

Detalles Bibliográficos
Autores principales: Modica, Chiara, Basilico, Cristina, Chiriaco, Cristina, Borrelli, Nicla, Comoglio, Paolo M., Vigna, Elisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807714/
https://www.ncbi.nlm.nih.gov/pubmed/33446252
http://dx.doi.org/10.1186/s13046-020-01822-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807714/
https://www.ncbi.nlm.nih.gov/pubmed/33446252
http://dx.doi.org/10.1186/s13046-020-01822-5

Ejemplares similares